Less Ads, More Data, More Tools Register for FREE

Pin to quick picksALM.L Regulatory News (ALM)

  • There is currently no data for ALM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Allied Minds Names Joseph Pignato as CFO

1 Sep 2015 07:03

RNS Number : 5800X
Allied Minds PLC
01 September 2015
 



Allied Minds Names Joseph Pignato as Chief Financial Officer

 

· Joe has served as a senior advisor to fast-growing businesses for almost two decades, and brings a wide range of experience working with venture capital firms as well as start-up and publicly traded companies.

 

· Joe was most recently CFO of Swipely, where he helped oversee growth in sales under management to more than $4 billion. He also served in senior management positions at Charles River Ventures, Prism Ventures and Lightbridge.

 

 

Boston (September 01, 2015) - Allied Minds (LSE: ALM), an innovative U.S. science and technology development and commercialization company, today announced that Joseph Pignato is joining its executive management team as Chief Financial Officer.

 

Joe's experience as a senior advisor to fast-growing businesses spans almost two decades. After gaining experience in accounting at PKF Worldwide and Deloitte, Joe developed expertise in the effective deployment of venture capital for early stage companies during his tenure as CFO of Charles River Ventures; as General Partner, Chief Operating Officer and CFO of Prism Ventures; and as a Board Member of the Slater Technology Fund. Joe also applied his own skills in value creation while serving as Director of Finance at Lightbridge, a NASDAQ-listed firm that he helped to take public; and as CFO at Swipely, which grew to more than $4 billion in sales under management during his tenure.

 

"It's a privilege to join Allied Minds, a company that brings together a unique mix of entrepreneurial talent and seasoned, global expertise," said Joe. "Allied Minds' dynamic and fast-moving environment is exciting, and I look forward to working with the team to help develop and support new companies in their innovative, and potentially market-disruptive, work."

 

Joe's broad strengths in finance, investor relations and operations, as well as his skills as a mentor to management teams, will be an asset to Allied Minds and its 22 subsidiary companies. At Allied Minds, Joe is joining an expanding team of experienced senior managers who are engaged in advising the portfolio companies on how to navigate high-growth strategies as they commercialize sophisticated technologies developed at U.S. federal and academic research centers.

 

"Joe brings a robust track record of managing and fostering early stage companies into financial stability and growth," said Chris Silva, Chief Executive Officer of Allied Minds. "I am confident that he will further enhance our ability to transform U.S. inventions into commercial innovation. We are delighted to have him on board the Allied Minds team."

 

More information about Allied Minds can be found at www.alliedminds.com

 

Media Contact:

 

US

Christine Dunn

ArcPoint Strategic Communications

cdunn@arcpointstrategy.com

617.484.1660 x101

 

UK

Ben Atwell / Matthew Cole

FTI Consulting

+44 (0) 20 3727 1000

 

About Allied Minds, Inc.

Allied Minds is an innovative U.S. science and technology development and commercialization company. Operating since 2006, Allied Minds forms, funds, manages and builds products and businesses based on innovative technologies developed at leading U.S. universities and federal research institutions. Allied Minds serves as a diversified holding company that supports its businesses and product development with capital, central management and shared services. More information about the Boston-based company can be found at www.alliedminds.com.

 

 

Allied Minds Forward-Looking Statement

This press release contains statements that are or may be forward-looking statements, including statements that relate to the company's future prospects, developments and strategies. The forward-looking statements are based on current expectations and are subject to known and unknown risks and uncertainties that could cause actual results, performance and achievements to differ materially from current expectations, including, but not limited to, those risk and uncertainties described in the risk factors included in the company's regulatory filings. These forward-looking statements are based on assumptions regarding the present and future business strategies of the company and the environment in which it will operate in the future. Each forward-looking statement speaks only as at the date of this press release. Except as required by law, regulatory requirement, the Prospectus Rules, the Listing Rules and the Disclosure and Transparency Rules, neither the company nor any other party intends to update or revise these forward-looking statements, whether as a result of new information, future events or otherwise.

 

###

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCPKDDDOBKDOFN
Date   Source Headline
13th Nov 20174:42 pmRNSBlocklisting Six Monthly Return
13th Nov 20174:24 pmRNSBlocklisting Six Monthly Return
31st Oct 20174:47 pmRNSTotal Voting Rights
30th Oct 20177:00 amRNSAllied-Bristol Life Sciences forms ABLS IV
25th Oct 20177:00 amRNSAllied Minds Capital Markets Day: 18 January 2018
16th Oct 20177:59 amRNSAllied Minds: STT and TEL to jointly develop MRAM
6th Oct 20174:42 pmRNSTotal Voting Rights
5th Oct 20177:00 amRNSSTT announces $22.8m convertible bridge facility
28th Sep 20177:00 amRNSSciFluor SF0166 study positive top-line results
19th Sep 20177:00 amRNSDirectorate Change
14th Sep 20177:00 amRNSFederated Wireless $42m fundraise & product launch
13th Sep 20174:40 pmRNSSecond Price Monitoring Extn
13th Sep 20174:35 pmRNSPrice Monitoring Extension
1st Sep 201711:43 amRNSTotal Voting Rights
17th Aug 20177:00 amRNSHalf-year Report
8th Aug 20175:36 pmRNSHolding(s) in Company
2nd Aug 20177:00 amRNSNotice of Results
26th Jul 20177:00 amRNSALM subsid Signature Medical $2.5 million Series A
12th Jul 20177:00 amRNSBridgeSat, Inc. appoints Barry Matsumori as CEO
11th Jul 20174:35 pmRNSSpin Transfer Tech's appoints Tom Sparkman CEO
30th Jun 20175:29 pmRNSTotal Voting Rights
29th Jun 20177:00 amRNSAppointment of Head of Technology Investments
13th Jun 20177:05 amRNSDirector/PDMR Shareholding
13th Jun 20177:05 amRNSDirector/PDMR Shareholding
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
13th Jun 20177:00 amRNSDirector/PDMR Shareholding
8th Jun 20177:00 amRNSDirector/PDMR Shareholding
8th Jun 20177:00 amRNSDirector/PDMR Shareholding
1st Jun 20175:02 pmRNSResult of AGM
30th May 20177:00 amRNSJill Smith Appointed As CEO and President
19th May 20174:58 pmRNSBlock Listing Six Monthly Return
12th May 20172:13 pmRNSBlock Listing of Shares
5th May 20177:00 amRNSBridgeSat raises $6 million in Series A financing
28th Apr 20173:14 pmRNSNotice of AGM; Annual Report
27th Apr 20177:00 amRNSAnnual Financial Report
20th Apr 20174:28 pmRNSHolding(s) in Company
18th Apr 20175:12 pmRNSHolding(s) in Company
7th Apr 20179:41 amRNSHolding(s) in Company
6th Apr 20175:24 pmRNSHolding(s) in Company
5th Apr 20174:35 pmRNSPrice Monitoring Extension
5th Apr 20177:00 amRNSReallocation of capital and resources
31st Mar 20173:56 pmRNSTotal Voting Rights
16th Mar 20175:27 pmRNSHolding(s) in Company
13th Mar 20177:00 amRNSJill Smith appointed interim CEO of Allied Minds
1st Mar 20174:45 pmRNSTotal Voting Rights
15th Feb 20172:57 pmRNSHolding(s) in Company
14th Feb 20174:23 pmRNSTotal Voting Rights
7th Feb 20177:00 amRNSHawkEye 360 Completes Second Closing of Series A

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.